These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 8930462)

  • 41. Renal graft survival is not influenced by a positive flow B-cell crossmatch.
    Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D
    Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA class I antibodies in patients awaiting kidney transplantation and the association with renal graft survival.
    Wu HH; Tien YC; Huang CI; Chiang YJ; Chu SH; Lai PC
    Transplant Proc; 2008 Sep; 40(7):2191-4. PubMed ID: 18790188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988.
    Persijn GG; D'Amaro J; De Lange P; Schreuder GM; Thorogood J; Zantvoort F; Van Rood JJ
    Clin Transpl; 1988; ():237-48. PubMed ID: 3154476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific HLA antibody production following renal transplantation.
    Martin S; Dyer PA; Gokal R; Mallick NP; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):898. PubMed ID: 3274885
    [No Abstract]   [Full Text] [Related]  

  • 46. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
    Navarro V; Herrine S; Katopes C; Colombe B; Spain CV
    Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of HLA-DR matching between living kidney donors and recipients and of pretransplant blood transfusions on graft survival.
    Akiyama N; Sugimoto H; Kusaba R; Takahashi I; Ohsawa N; Inou T; Samaru Y
    Jpn J Exp Med; 1981 Feb; 51(1):37-43. PubMed ID: 6458714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal transplant graft survival results and HLA-A,B, DR mismatching.
    Cicciarelli J; Iwaki Y; McCalmon R; Thompson J
    Transplant Proc; 1995 Feb; 27(1):660-3. PubMed ID: 7879135
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of HLA matching on survival in heart transplantation.
    Almenar L; Maeso ML; Martínez-Dolz L; Rueda J; Palomar CG; Sáez AO; Vives MA; Tort MD; Pérez MP
    Transplant Proc; 2005 Nov; 37(9):4001-5. PubMed ID: 16386610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
    Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HLA and MICA antibodies: further evidence of their impact on graft loss two years after their detection.
    Morales-Buenrostro LE; Rodríguez-Romo R; de Leo C; López M; Pérez-Garrido J; Uribe-Uribe N; Alberú J
    Clin Transpl; 2006; ():207-18. PubMed ID: 18365379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response.
    Waanders MM; Roelen DL; Brand A; Claas FH
    Transfus Med Rev; 2005 Oct; 19(4):281-7. PubMed ID: 16214017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunological selection of donors and recipients in renal grafts: antibodies].
    Seignalet J; Mourad G; Mion C
    Nephrologie; 1984; 5(1):33-9. PubMed ID: 6374486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection.
    Lordon RE; Wilson RL; Shield CF; Ferrone S
    Transplantation; 1981 Oct; 32(4):286-90. PubMed ID: 7036445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of HLA antibodies and its impact on graft function in a group of kidney transplant recipients: a cross-sectional study.
    Morales-Buenrostro LE; Buzo-Romero JM; de Leo C; López M; Ortiz-Arroyo VM; Pérez-Garrido J; Herrera-Garcia C; Granados J; Alberú J
    Transplant Proc; 2006 Apr; 38(3):899-902. PubMed ID: 16647503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.